Novo Nordisk announces strategic partnership with OpenAI

Novo Nordisk announced a strategic partnership with OpenAI on April 14th. This collaboration will leverage advanced artificial intelligence capabilities to analyze complex datasets, identify promising drug candidates, and shorten the cycle from basic research to patient benefit. (Interface)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin